Antiphospholipid Syndrome
What's New
Last Posted: Apr 20, 2023
- Thrombophilia Testing - a Systematic Review.
Lars Asmis et al. Clin Lab 2023 69(4) - Clinical Utilization and Cost of Thrombophilia Testing in Patients with Venous Thromboembolism.
Gaddh Manila et al. TH open : companion journal to thrombosis and haemostasis 2020 Jul 4(3) e153-e162 - CLINGEN Actionability Report for Factor V Leiden, Homozygous (also includes compound heterozygous FVL + prothrombin G20210A) - F5
ClinGen Actionability Working Group - CLINGEN Actionability Report for Factor V Leiden, Heterozygous - F5
ClinGen Actionability Working Group - Recurrent pregnancy loss evaluation combined with 24-chromosome microarray of miscarriage tissue provides a probable or definite cause of pregnancy loss in over 90% of patients.
Popescu F et al. Human reproduction (Oxford, England) 2018 Mar - Thrombophilia testing results in patients with a first venous thromboembolic event: should the selection criteria for testing be revisited?
Hirmerova Jana et al. International angiology : a journal of the International Union of Angiology 2017 Apr 36(2) 167-173 - Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach.
Mariani Louise-Laure et al. JAMA neurology 2016 Jul - Preimplantation Genetic Diagnosis and Natural Conception: A Comparison of Live Birth Rates in Patients with Recurrent Pregnancy Loss Associated with Translocation.
Ikuma Shinichiro et al. PLoS ONE 2015 10(6) e0129958 - Antiphospholipid Antibody Syndrome
From NHLBI health topic site - Antiphospholipid syndrome
From NCATS Genetic and Rare Diseases Information Center
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: